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Abstract 
Epidemiological studies have suggested a negative association between early life arsenic 
exposure and fetal size at birth, and subsequently with child morbidity and growth. However, our 
understanding of the relationship between arsenic exposure and morbidity and growth is limited.  
This paper aims to systematically review original human studies with an analytical 
epidemiological study design that have assessed arsenic exposure in fetal life or early childhood 
and evaluated the association with one or several of the following outcomes: fetal growth, birth 
weight or other birth anthropometry, infant and child growth, infectious disease morbidity in 
infancy and early childhood.  A literature search was conducted in PubMed, TOXLINE, Web of 
Science, SciFinder and Scopus databases filtered for human studies. Based on the predefined 
eligibility criteria, two authors independently evaluated the studies. A total of 707 studies with 
morbidity outcomes were identified, of which six studies were eligible and included in this 
review. For the growth outcomes a total of 2,959 studies were found, and nine fulfilled the 
criteria and were included in the review. A majority of the papers (10/15) emanated from 
Bangladesh, three from the USA, one from Romania and one from Canada. All included studies 
on arsenic exposure and morbidity showed an increased risk of respiratory tract infections and 
diarrhea. The findings in the studies of arsenic exposure and fetal, infant and child growth were 
heterogeneous. Arsenic exposure was not associated with fetal growth. There was limited 
evidence of negative associations between arsenic exposures and birth weight and growth during 
early childhood.  More studies from arsenic affected low- and middle-income countries are 
needed to support the generalizability of study findings. 
Keywords: Arsenic, human studies, growth, morbidity, systematic review 
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Background 
Arsenic concentration in groundwater exists in many parts of the world and is a major public 
health concern in these settings (Mukherjee et al. 2006; Ng et al. 2003). Millions of people are 
exposed through drinking water to arsenic concentrations above the World Health Organization 
guideline value of 10g/L (Smith et al. 2000). However, the level of exposure is particularly 
great in Bangladesh and West Bengal, India. Arsenic is a potent toxicant and carcinogen. 
Epidemiological studies have reported an association between arsenic exposure and increased 
risks of various cancers and non-cancerous diseases. These include skin lesions (Rahman et al. 
1999a; Tondel et al. 1999), hypertension (Rahman et al. 1999b), cardiovascular and respiratory 
diseases (Milton and Rahman 2002; Moon et al. 2013), diabetes mellitus (Navas-Acien et al. 
2008) and malignancies of skin and internal organs (IARC 2004). Arsenic can easily pass 
through the placenta and poses a threat to early human development (Vahter 2009). A number of 
studies have reported an association between prenatal arsenic exposure and adverse pregnancy 
outcomes such as spontaneous abortions (Milton et al. 2005; Rahman et al. 2007), stillbirths 
(Milton et al. 2005; von Ehrenstein et al. 2006), low birth weight (Rahman et al. 2009), and 
infant mortality.  All these adverse health outcomes may affect the progress of an overall health 
envisioned by the Sustainable Development Goals.  
 
Bangladesh has shown significant achievements in the reduction of child mortality (NIPORT 
2014; UNICEF 2015). However, the success has been limited in efforts to reduce morbidity and 
improve growth of fetuses and children. For example, recent studies have reported that the 
prevalence of small for gestational age at birth is 36% and stunting at five years of age is 45% 
(Mridha et al. 2016; Svefors et al. 2016). Morbidity and growth are interrelated and may 
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influence future development and survival of children. Epidemiological studies have suggested a 
negative association between early life arsenic exposure and fetal size at birth, and subsequently 
with morbidity and growth during childhood (Gardner et al. 2013; Rahman et al. 2009). 
However, our understanding of the relationship between arsenic exposures and morbidity and 
growth is limited. A previous systematic review evaluated the association between arsenic 
exposure and adverse pregnancy outcomes with a focus on spontaneous abortion, stillbirth, birth 
outcomes and mortality during infancy and childhood (Quansah et al. 2015). This paper aims at 
systematically review original human studies with an analytical epidemiological study design 
that measure arsenic exposure in fetal life or early childhood, and evaluates the association with 
one or several of the following outcomes: fetal growth, birth weight or other birth 
anthropometry, infant and child growth, infectious disease morbidity in infancy and early 
childhood. 
 
Methods 
 
A literature search was conducted 9-13 May 2016 in PubMed 
(https://www.ncbi.nlm.nih.gov/pubmed/), TOXLINE (https://toxnet.nlm.nih.gov/cgi-
bin/sis/htmlgen?TOXLINE), Web of Science (https://webofknowledge.com), SciFinder 
(http://www.cas.org/products/scifinder) and Scopus (https://www.scopus.com/) databases filtered 
for human studies. Keywords used were "arsenic", "fetal", "birth weight", "infant growth", "child 
growth", "infant morbidity" and "child morbidity". The term "arsenic" was combined with all of 
the other search terms. The articles were screened via title and abstract and excluded if not 
eligible. Two authors (CG, LÅP) evaluated the articles independently based on inclusion and 
exclusion criteria and articles included in this review fulfilled the following eligibility criteria a) 
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original study; b) case-control or cohort study design, i.e. a longitudinal design ascertaining that 
exposure came before outcome; c) human study; d) English language; e) arsenic exposure; f) one 
or more of the following outcomes: fetal growth, birthweight, infant growth, child growth, infant 
infectious morbidity, child infectious morbidity. Studies were excluded if being reviews or meta-
analyses. Studies with an ecological design were not included. 
 
Due to the differences in design, sources of arsenic exposure assessments (drinking water, urine, 
blood, hair, nails), classification of levels of exposure, outcome data collection and classification, 
and statistical analyses employed we did not include any meta analysis. The quality of the 
included studied was assessed according to the Newcastle-Ottawa Quality Assessment Scale for 
Case-Control or Cohort Studies (Wells et al. 2013). The results of the included studies were 
reviewed and discussed for the different outcomes as to the quality of studies, consistency of 
findings, contextual factors, and strength of associations. 
 
Results 
A total of 707 studies with morbidity outcomes were identified, of which six studies were 
eligible and included in this review (Figure 1). For the growth outcomes a total of 2,959 studies 
were found, and nine fulfilled the criteria and were included in the review (Figure 2). A majority 
of the papers (10/15) emanated from Bangladesh, and three were from the USA, one from 
Romania and one from Canada. Two of the morbidity studies (Rahman et al. 2011; Raqib et al. 
2009) and four of the growth studies (Gardner et al. 2013; Kippler et al. 2012; Rahman et al. 
2009; Saha et al. 2012) were based on the MINIMat trial and cohort (Maternal and Infant 
Nutrition Interventions, Matlab) in rural Bangladesh (Persson et al. 2012). Two of the US studies 
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of arsenic and child morbidity were also based on different selections of the same cohort (Farzan 
et al. 2013; Farzan et al. 2016). 
 
Arsenic exposure and infant and child morbidity 
All included studies, two US studies from the same cohort (Farzan et al. 2013; Farzan et al. 
2016) as well as in the Bangladeshi studies (George et al. 2015; Rahman et al. 2011; Raqib et al. 
2009; Smith et al. 2013), showed an increased morbidity risk when exposed to arsenic (Table 1). 
All papers addressed respiratory outcomes. In the Bangladeshi case-control study child urinary 
arsenic levels were associated with higher risk of pneumonia (George et al. 2015), and in the 
MINIMat cohort prenatal urinary arsenic was linked to an increased risk of lower respiratory 
tract infections (Rahman et al. 2011). Maternal urinary arsenic levels were associated with 
respiratory symptoms or upper respiratory tract infections demanding certain health service 
attention in the American as well as the Bangladeshi studies (Farzan et al. 2013; Farzan et al. 
2016; Raqib et al. 2009). In another Bangladeshi cohort it was also shown that drinking water 
arsenic levels in pregnancy and childhood were associated with child wheezing and 
breathlessness (Smith et al. 2013). In the American as well as the MINIMat cohort in Bangladesh 
the prenatal urinary arsenic levels were associated with higher risk of childhood diarrhea (Farzan 
et al. 2016; Rahman et al. 2011). 
 
Arsenic exposure and fetal, infant and child growth 
There was only one study employing a longitudinal analysis of prenatal arsenic exposure and 
ultrasound-based fetal growth outcomes, Table 2 (Kippler et al. 2012). Six studies had an 
outcome with birth weight or other measurements of size at birth (Bloom et al. 2016; Gilbert-
 7 
Diamond et al. 2016; Huyck et al. 2007; Kile et al. 2016; Rahman et al. 2009; Thomas et al. 
2015). Two studies, based on the MINIMat cohort, evaluated the association between arsenic 
exposure and infant or young child growth (Gardner et al. 2013; Saha et al. 2012).  
 
There was no association between prenatal arsenic exposure assessed by urine samples and 
ultrasound assessment of fetal growth parameters from week 8 to 30 in rural Bangladesh, Table 2 
(Kippler et al. 2012). In the same cohort maternal urinary arsenic in the range below 100 µg/L 
was negatively associated with birth weight, head, and chest circumference but not with birth 
length (Rahman et al. 2009). Above that level of exposure no further increase in the negative 
association was found. In another Bangladeshi cohort arsenic in maternal drinking water as well 
as in toenails was negatively associated with birth weight. A major part of that association was 
mediated over gestational age at birth (Kile et al. 2016). Another small Bangladesh pregnancy 
cohort showed a negative association between maternal hair arsenic levels and birth weight 
(Huyck et al. 2007). The studies from the US and Romania did not show any overall associations 
between prenatal arsenic exposure and birth weight. In the American study stratifications by 
maternal weight groups and infant sex showed that urinary arsenic of overweight mothers was 
positively associated with birth length in boys and negatively associated with birth weight in 
girls (Gilbert-Diamond et al. 2016). There were no adjustments done for other potential 
confounders. In the Romanian cohort study a negative association between prenatal drinking 
water arsenic levels and birth weight and length was only seen among smoking mothers (Bloom 
et al. 2016). 
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The growth follow-up of the MINIMat cohort to two years (Saha et al. 2012) and later to five 
years (Gardner et al. 2013) showed that the strongest negative association between arsenic 
exposure and growth (weight and height) was seen with the concurrent exposure and among 
girls. Even here the strongest association was seen in a lower range of exposure (Gardner et al. 
2013). 
 
Discussion 
This systematic review has shown that arsenic exposure is associated with an increased risk of 
infant and child respiratory infections and diarrhea, and, less consistent, with impaired growth.  
 
This review was based on a comprehensive search of articles, and two authors had independently 
reviewed and selected the articles based on predefined criteria. We also recognize the potential 
weakness of using the Newcastle-Ottawa Quality Assessment Scale, which may be prone to bias. 
Some studies have reported poor agreement between reviewers and authors of the reviewed 
articles when ranking the quality (Lo et al. 2014). In addition, the external validity and 
generalizability of the study findings were compromised due to the bulk of the studies conducted 
in Bangladesh. No studies regarding these outcomes are so far available from other arsenic-
affected low- and middle-income countries.  
 
The articles selected for this systematic review evaluated the association of early life arsenic 
exposures with morbidity limited to respiratory infections and diarrhea during infancy and 
childhood. The findings were more or less consistent, although the individual studies differed 
from each other in design, exposure and outcome assessments, and selection of study 
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participants. In the case-control study, physicians assessed the outcome based on criteria set by 
the World Health Organization (George et al. 2015), while the other high-ranked study defined 
the outcomes based on reported symptoms (Rahman et al. 2011). These high-ranked studies 
reported about two times increased risk of respiratory infections in the higher exposure levels in 
comparison with the low-level exposure. These studies also found mild to moderate risk of 
diarrhea based on reported symptoms. Overall, the findings suggest effects of arsenic on 
common childhood morbidity that are of public health importance.  These infections are also 
among the main causes of under-five mortality (Liu et al. 2015).   
  
The findings of consequences of arsenic exposure on fetal, infant, and child growth were not 
consistent. Two studies, which evaluated the effect on fetal growth and SGA at birth, did not 
show any association. Three studies from Bangladesh had reported negative associations with 
birthweight, while the studies in Romania and USA, respectively, only demonstrated an 
association in sub-groups of the study population. Thus, these studies provide no evidence of an 
association with fetal growth and limited evidence regarding effects on birthweight. The studies 
in Bangladesh, based on the MINIMat cohort, demonstrated a sex-dependent association with 
child growth; the possible effects were shown in girls.   
 
The suggested associations between arsenic exposures and childhood morbidity may be mediated 
via immune suppression. In experimental studies, arsenic exposure has been found to suppress 
the immunoglobulin (Ig)M and IgG antibody-forming cell response (Selgrade 2007) and 
decrease interleukin-2 mRNA expression (Conde et al. 2007). Arsenic exposure during 
pregnancy has also been associated with fewer T-cells (CD3+ cells) in the placenta (Ahmed et al. 
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2011). The mechanisms by which arsenic exposure potentially affects fetal and early childhood 
growth are less clear.  Arsenic is suggested to induce oxidative stress by producing free oxygen 
radicals or by perturbation of oxidative defense leading to placental insufficiency including intra-
uterine growth retardation (Vahter 2007). Epidemiological studies have demonstrated 
associations between arsenic exposure and anemia. Growth impairment may also be a 
consequence of anemia in children (Gardner et al. 2013; Heck et al. 2008; Sazawal et al. 2010). 
 
In conclusion, arsenic exposure is associated with an increased risk of childhood respiratory tract 
infections and diarrhea. The evidence is so far weak regarding associations between arsenic 
exposure and fetal growth, size at birth, and growth during childhood.  Present results mostly 
emanate from studies conducted in Bangladesh. Millions of people are still exposed to arsenic, 
and pregnant women drink arsenic-contaminated water (Smith et al. 2000). The earlier 
demonstrated increased child mortality risk (Quansah et al. 2015), the increased risk of child 
infections, and the suggested impaired growth demonstrates the public health importance of this 
toxic exposure. Concerted actions and effective mitigation programs are needed in the affected 
countries, with priority given to women of reproductive age and their children. 
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Figure 1. The study selection flow diagram, morbidity outcomes.   
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Figure 2. The study selection flow diagram, fetal growth, low birthweight and infant and child 
growth outcomes.   
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Table 1. Characteristics of studies with arsenic exposure and infant or child morbidity outcome  
Author Countr
y 
Study 
desig
n 
Study 
populatio
n 
Exposur
e 
Outcome  Adjustment for 
confounders 
Results Quality
a 
Farzan 
et al. 
(2016) 
 
USA Cohor
t 
Mother-
infant 
pairs, 
n=412 
U-As 
during 
pregnanc
y 
Respirator
y 
infections, 
fever, 
diarrhea 
Maternal age, parity, 
smoking, infant sex, 
gestational age, birth 
weight, 
breastfeeding, day 
care attendance 
Doubling U-As associated with an 
increased risk of medical consultation for 
infection (RR 1.1; 95% CI 1.0, 1.2), 
respiratory symptoms >2 days (RR 1.1; 
95% CI 1.0, 1.2). Also association with 
diarrhea (RR 1.4; 95% CI 1.1, 1.9) and 
fever resulting in doctor visit (RR 1.2; 95% 
CI 1.0, 1.5) 
7/9 
George 
et al. 
(2015) 
 
Bangla
desh 
Case-
contro
l 
Children, 
cases 
n=153, 
controls 
n=296 
Child U-
As. 
Lowest 
quartile 
<6 μg/L 
Pneumoni
a 
U-Creatinine, weight 
for height, 
breastfeeding, 
paternal age, 
education, household 
size 
U-As associated with risk of pneumonia. 
OR for quartiles U-As: 1.00 (reference), 
1.75 (95 % CI 0.90, 3.40), 2.11 (95 % CI 
1.01, 4.34)), and 2.04 (95 % CI 0.92, 4.51). 
9/9 
Farzan 
et al. 
(2013) 
 
USA Cohor
t 
Mother-
infant 
pairs, 
n=214 
 
U-As 
during 
pregnanc
y 
Respirator
y 
infections, 
diarrhea 
Maternal age, parity, 
child sex, gestational 
age, birth weight, 
breastfeeding, day 
care attendance 
U-As associated with any upper respiratory 
tract infection with prescribed treatment at 
4 months (RR 1.6; 95% CI 1.0, 2.5), any 
lower respiratory tract infection treated 
with prescription (RR 1.6; 95% CI 1.0, 
2.5) 
6/9.  
 
Smith 
et al. 
(2013) 
Bangla
desh 
Cohor
t 
Children, 
n=495 
W-As in 
pregnanc
y and 
childhoo
d 
Pulmonary 
effects, 
asthma, 
wheezing  
Age, gender, 
mother’s education, 
father’s education, 
father’s smoking 
status, rooms in the 
house 
W-As associated with wheezing (OR 8.41, 
95% CI 1.66, 42.6), shortness of breath if 
walking on level ground (OR 3.86, 95% CI 
1.09, 13.7) or walking fast or climbing 
(OR 3.19, 95% CI 1.22, 8.32). Reference 
category As exposure <10µg/l 
6/9 
Rahma
n et al. 
Bangla
desh  
Cohor
t 
Mother-
infant 
U-As 
during 
Lower 
respiratory 
Maternal education, 
household asset 
Maternal U-As associated with the risk of 
LRTI (RR 1.69; 95% CI, 1.36, 2.09) and 
8/9 
 20 
(2011) 
 
pairs, 
n=1552 
pregnanc
y 
tract 
infection 
(LRTI), 
diarrhea  
scores, parity, body 
mass index, 
gestational age, 
infant sex 
diarrhea (RR = 1.20; 95% CI, 1.21, 1.97) 
when comparing the highest and lowest 
exposure quintiles. 
Raqib 
et al. 
(2009) 
 
Bangla
desh 
Cohor
t  
Mother-
infant 
pairs, 
n=140 
 
U-As 
during 
pregnanc
y 
Acute 
respiratory 
infections 
(ARI) 
Child BMI SD score, 
maternal BMI, 
household asset 
score, child sex 
U-As at week 30 of gestation significantly 
associated with days of ARI 0-12 months 
6/9 
 
a
The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses (Wells et al. 2013) 
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Table 2. Characteristics of studies with arsenic exposure and fetal growth, size at birth and infant and child growth outcomes  
Author Countr
y 
Study 
desig
n 
Study 
populatio
n 
Exposure Outcom
e 
Adjustment for confounders Results Quality
a 
Kippler 
et al. 
(2012)  
Bangla
desh 
Cohor
t  
Pregnant 
women, 
n=1929 
U-As wk 8 
and 30 
Fetal size 
wk 8, 14, 
30 
Maternal BMI, household asset 
score, birth order, fetal sex 
No association U-As and fetal 
size in adjusted longitudinal 
analysis 
8/9 
Gilbert-
Diamon
d et al. 
(2016)  
USA Cohor
t 
Mother-
infant 
pairs, 
n=706 
Maternal 
U-As in 
pregnancy 
Size at 
birth 
Stratification for maternal weight 
group, infant sex 
U-As of overweight mothers 
positively associated with birth 
length in boys, negatively 
associated with birth weight in 
girls 
7/9 
Kile  et 
al. 
(2016)  
Bangla
desh 
Cohor
t 
Mother-
infant 
pairs, 
n=1140 
(toenails 
n=624) 
W-As in 
pregnancy 
and As in 
toenails 
Birth 
weight 
Mediation analyses gestational 
age, maternal weight gain. 
Adjustments infant sex, maternal 
education, indirect tobacco 
smoke, BMI, maternal age, birth 
type and location 
W-As as well as toenail As 
negatively associated with 
birth weight; most mediated 
over gestational age at birth 
7/9 
Bloom 
at al. 
(2016)  
Romani
a 
Cohor
t 
Mother-
infant 
pairs, 
n=122 
W-As in 
pregnancy 
Size at 
birth  
Maternal age, pre-pregnancy 
BMI, education 
 
No association pregnancy W-
As and size at birth. Smokers: 
higher W-As (Δ 10µg/L) 
negatively associated with 
birth weight and length  
8/9 
Thomas 
et al. 
(2015)  
Canada Cohor
t 
Mother-
infant 
pairs, 
n=1835 
U-As and 
As in 
blood in 
pregnancy 
SGA
2 
Maternal age, parity, pre-
pregnancy BMI, smoking 
No association between arsenic 
exposure and SGA 
8/9 
Rahman 
et al. 
(2009)  
Bangla
desh 
Cohor
t  
Mother-
infant 
pairs, 
n=1578 
U-As in 
pregnancy 
Size at 
birth 
Household asset score, maternal 
BMI, height, age and education, 
season, gestational age at birth, 
sex of infant 
U-As below 100 µg/L 
negatively associated with 
birth weight, head and chest 
circumferences. Above this 
level no negative association 
8/9 
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Huyck 
et al. 
(2007)  
Bangla
desh 
Cohor
t 
Mother-
infant 
pairs, 
n=43 
W-As and 
As in 
toenail, 
hair 
Birth 
weight 
Gestational age at first prenatal 
visit, activity level, maternal 
weight gain, gestational age at 
birth  
Maternal hair As negatively 
associated with birth weight 
7/9 
 
Saha et 
al. 
(2012)  
Bangla
desh 
Cohor
t  
Children, 
n=2372 
U-As in 
pregnancy 
and 
childhood 
Weight 
and 
length up 
to 2 
years of 
age 
Age and sex of child, maternal 
BMI, household asset score 
 
Maternal U-As inversely 
associated with length at 3 
months. Child U-As at 18 
months inversely associated 
with weight and height to 24 
months, particularly in girls 
8/9 
 
 
Gardner 
et al. 
(2012)  
Bangla
desh  
Cohor
t  
Mother-
infant 
pairs, 
n=1505 
U-As in 
pregnancy 
and 
childhood 
Weight, 
height up 
to 5 
years of 
age 
Child’s sex, season of birth, 
gestational age at birth, birth 
order, household asset score, 
maternal education, maternal 
height or body mass index, 
maternal tobacco-chewing, indoor 
cooking 
U-As in pregnancy and 
childhood inversely associated 
with height and weight at age 5 
years. The strongest 
association with concurrent 
exposure, among girls, and in 
the lower range of exposure 
7/9  
SGA Small for gestational age
 
a
The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 
 
 
 
 
